Right ventricular (RV) size and function inform prognosis in many cardiovascular diseases, but assessment by two-dimensional transthoracic echocardiography is challenging. Here we show that a deep learning model, Dimensional Reconstruction of Imaging Data-Right Ventricle (DROID-RV), can estimate RV end-diastolic diameter and identify RV systolic dysfunction from transthoracic echocardiography videos. We trained DROID-RV in 17,141 ambulatory… Continue reading Deep learning-enabled assessment of right ventricular size and function is associated with cardiovascular outcomes
Tag: CVD
Vitamin B12 and cardiovascular health: mechanisms, clinical evidence, and future directions
Cardiovascular disease (CVD) continues to be the primary cause of morbidity and death globally. New research shows that vitamin B₁₂ is very important for vascular health since it controls homocysteine metabolism, endothelial function, and one-carbon pathways. Deficiency not only causes hyperhomocysteinemia, oxidative stress, and vascular damage, but it also affects epigenetic pathways associated with atherosclerosis.… Continue reading Vitamin B12 and cardiovascular health: mechanisms, clinical evidence, and future directions
Retinal and coronary imaging in type 1 diabetes: links between retinopathy and subclinical cardiovascular disease
Cardiovascular disease (CVD) remains the leading cause of premature morbidity and mortality in individuals with type 1 diabetes mellitus (T1DM), despite advances in glycemic management and cardiovascular prevention. Conventional cardiovascular risk assessment may underestimate risk in T1DM, particularly among younger asymptomatic individuals, highlighting the need for markers of early vascular injury. Diabetic retinopathy (DR), a… Continue reading Retinal and coronary imaging in type 1 diabetes: links between retinopathy and subclinical cardiovascular disease
Impact of Simulated Risk Factor Management on Cardiovascular Disease and Costs in Type 2 Diabetes Using the ABC Model
Aims: We evaluated the impact of scenario-based multifactorial control on the 3-year incidence of fatal/non-fatal cardiovascular disease (#CVD ) and associated healthcare costs in Asian patients with type 2 diabetes (#T2D ).Materials and methods: We applied the validated 'ABC' model to simulate the 3-year impact of attaining multiple treatment targets (HbA1c < 7%, blood pressure… Continue reading Impact of Simulated Risk Factor Management on Cardiovascular Disease and Costs in Type 2 Diabetes Using the ABC Model
Effects of #finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 #diabetes and chronic #kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Background: The mechanisms underlying cardiorenal benefits of finerenone remain unclear. This mechanistic trial aimed to evaluate the effects of finerenone on vascular stiffness, as assessed using the cardio-ankle vascular index (CAVI), and cardiorenal biomarkers in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).Methods: Eligible patients with T2D and CKD (estimated glomerular filtration… Continue reading Effects of #finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 #diabetes and chronic #kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Association between frequency of meeting daily step thresholds and all-cause #mortality and #cardiovascular disease in older women
Objective To examine the associations between the number of days per week achieving various daily step thresholds and all-cause mortality and cardiovascular disease (CVD) incidence in older women.Methods We conducted a prospective cohort study of 13 547 women free of CVD and cancer (mean age 71.8 years). We included participants who wore an ActiGraph GT3X+ accelerometer for… Continue reading Association between frequency of meeting daily step thresholds and all-cause #mortality and #cardiovascular disease in older women
MRI markers of #cerebrospinal fluid dynamics predict #dementia and mediate the impact of #cardiovascular risk
INTRODUCTIONImpaired cerebrospinal fluid (CSF) dynamics may contribute to dementia, but human evidence is limited. We examined associations between magnetic resonance imaging–based proxies of CSF dynamics and incident dementia, and whether CSF dysfunction mediates links between cardiovascular risk and dementia.METHODSUsing the UK Biobank, we measured CSF dynamics: perivascular space (PVS) volume, diffusion tensor image analysis along… Continue reading MRI markers of #cerebrospinal fluid dynamics predict #dementia and mediate the impact of #cardiovascular risk
Timing and combinations of #cardiovascular diseases in survivors of childhood, adolescent, and young adulthood #cancer
Children, adolescents, and young adults with cancer (referred to as CAYAs) are at risk of long-term health complications, with cardiovascular disease (CVD) being a major concern. In addition, sociodemographic characteristics and traditional cardiovascular risk factors may also contribute to disparities in outcomes compared with those of the general population.The aim of this study was to… Continue reading Timing and combinations of #cardiovascular diseases in survivors of childhood, adolescent, and young adulthood #cancer
A New Paradigm to Reduce Cardiovascular #Disease Based on the Pathogenesis of #Atherosclerosis
Atherosclerotic coronary artery disease is the number one cause of morbidity and mortality in the United States, Europe, and Westernized countries. This review recommends a new paradigm for the reduction of atherosclerotic coronary artery disease, namely prevention and treatment by addressing the pathophysiological basis of atherosclerotic disease. This paradigm utilizes the role of cholesterol transport… Continue reading A New Paradigm to Reduce Cardiovascular #Disease Based on the Pathogenesis of #Atherosclerosis